poisar

Stocks · News reference

Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

BenzingaBenzinga Newsdesk

Truist Securities analyst Richard Newitter initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $29.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading